Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$278M |
| 2 |
Exxon Mobil
XOM
|
+$270M |
| 3 |
Verizon
VZ
|
+$141M |
| 4 |
Yum China
YUMC
|
+$135M |
| 5 |
Chevron
CVX
|
+$122M |
Top Sells
Sector Composition
| 1 | Financials | 17.74% |
| 2 | Technology | 15.29% |
| 3 | Industrials | 12.37% |
| 4 | Healthcare | 11.81% |
| 5 | Consumer Discretionary | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Patriot National Bancorp
PNBK
$138M
| $212K | ﹤0.01% |
20,193
+2,811
| +16% | +$29.5K |
|
|
SRAX
3227
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
| $212K | ﹤0.01% |
123,800
-13,058
| -10% | -$22.4K |
|
|
SURF
3228
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $210K | ﹤0.01% |
202,064
-428,414
| -68% | -$445K |
|
3229
Samsara
IOT
$22.1B
| $209K | ﹤0.01% |
+17,313
| New | +$209K |
|
3230
BioAtla
BCAB
$39.2M
| $207K | ﹤0.01% |
+26,861
| New | +$207K |
|
|
SOHO
3231
Sotherly Hotels
SOHO
$16M
| $206K | ﹤0.01% |
109,659
| – | – |
|
|
ICAD
3232
DELISTED
iCAD Inc
ICAD
| $203K | ﹤0.01% |
96,608
+28,840
| +43% | +$60.6K |
|
|
ALLK
3233
DELISTED
Allakos
ALLK
| $202K | ﹤0.01% |
33,032
+735
| +2% | +$4.5K |
|
3234
Eletrobras Preferred Shares
EBR.B
$20.1B
| $202K | ﹤0.01% |
24,031
| – | – |
|
3235
Home Federal Bancorp
HFBL
| $202K | ﹤0.01% |
+10,803
| New | +$202K |
|
3236
Blend Labs
BLND
$1.07B
| $201K | ﹤0.01% |
+90,701
| New | +$201K |
|
3237
Akebia Therapeutics
AKBA
$777M
| $199K | ﹤0.01% |
627,549
-155,126
| -20% | -$49.2K |
|
|
VXRT
3238
DELISTED
Vaxart
VXRT
| $198K | ﹤0.01% |
91,095
-27,984
| -24% | -$60.8K |
|
|
FNCB
3239
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $197K | ﹤0.01% |
26,276
+2,291
| +10% | +$17.2K |
|
3240
SK Telecom
SKM
$8.33B
| $196K | ﹤0.01% |
10,201
+6
| +0.1% | +$115 |
|
3241
Terns Pharmaceuticals
TERN
$654M
| $196K | ﹤0.01% |
+33,312
| New | +$196K |
|
|
IMAB
3242
I-MAB
IMAB
$341M
| $194K | ﹤0.01% |
+48,437
| New | +$194K |
|
3243
Petco
WOOF
$1B
| $194K | ﹤0.01% |
17,363
+2,859
| +20% | +$31.9K |
|
|
AXLA
3244
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $194K | ﹤0.01% |
4,523
+880
| +24% | +$37.7K |
|
3245
RxSight
RXST
$410M
| $193K | ﹤0.01% |
+16,115
| New | +$193K |
|
|
TWKS
3246
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $193K | ﹤0.01% |
+18,406
| New | +$193K |
|
3247
Exagen
XGN
$212M
| $191K | ﹤0.01% |
70,511
+1,698
| +2% | +$4.6K |
|
|
AVEO
3248
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $191K | ﹤0.01% |
23,227
-1,800
| -7% | -$14.8K |
|
|
SYRS
3249
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $190K | ﹤0.01% |
+29,524
| New | +$190K |
|
|
SPPI
3250
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $189K | ﹤0.01% |
439,723
-20,162
| -4% | -$8.67K |
|